An understanding of the basic approach to creating vaccines, as well as how vaccines confer immunity, is essential to developing safe and cost-effective formulations.
Increasing energy demand and dwindling energy resources have spurred interest in making transportation fuels from renewable sources such as microalgae.
The individual technical elements of the algae-to-biofuels process have already been demonstrated at the laboratory scale. Ongoing research seeks to refine the technology to enable scaleup to commercial production.
Stem cells are poised to transform medical treatments for a host of diseases and malignant conditions. Translating stem cell research into clinical therapies, disease models, and drug-screening platforms will require a combination of sound science...
The production of stem-cell-based therapeutic products in large quantities is more complex than manufacturing molecular drugs. Scale-up and scale-out challenges arise related to the type of stem cell, cell expansion and banking, sterile handling,...
Establishing scalable technology platforms that allow for varying levels of production throughout the different stages of clinical testing can minimize process development timelines, drug-comparability risks, and — ultimately — costs.
Blake A. Simmons, Bradley M. Holmes, Harvey W. Blanch, Seema Singh
Ionic liquids show promise as lignocellulosic biomass solvents. But is this approach a scientific curiosity or a commercially viable biofuel pretreatment technology?
David Hogsett, Eduardo Ximenes, Michael R. Ladisch, Nathan S. Mosier, Youngmi Kim
Biochemical and thermochemical process technologies being developed to convert wood and other lignocellulosic feedstocks to liquid fuels will drive the transition from corn-based ethanol to advanced biofuels.